Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? - Wikidata - awgldk - TriplyDB

Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?

Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?

http://www.wikidata.org/entity/Q53286113

about

Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases?

P2860

Q57169367-7EE440A1-C1CD-4451-8DA9-EBEF0EA25C44

P2860

Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?

http://www.wikidata.org/entity/Q53286113

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?

@en

Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?

@nl

type

label

Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?

@en

Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?

@nl

prefLabel

Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?

@en

Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?

@nl

P1433

Q53286113-E4766355-0167-4FE0-9B6C-C1B8E9116F43

P1476

Q53286113-452704A6-FDCB-4D69-A466-5A891529F57D

P2093

Q53286113-33C622E3-9552-4120-8DDC-5A32551CCB15

Q53286113-3BC4DE2D-EB8E-4CB3-8F00-EA3B18F312ED

Q53286113-513E6EBF-8C0F-48A9-B0A6-D6E4B6225E08

Q53286113-54BE3669-6ED7-4FB4-B83B-0FA6E4208003

Q53286113-5EE63529-1804-4CE8-B644-8A3A58C83695

Q53286113-83C19A7D-C73F-4237-89D9-9F3DA0BC9D0B

Q53286113-A66BAE54-5036-4495-A243-930033A6D68A

Q53286113-A7DA650D-48A0-4DBE-8352-8CB6AD618118

Q53286113-B768CDB5-D625-4101-AE1F-D59ACF8C9C3D

Q53286113-DD901F03-3FE0-46F3-A979-2DA4683E13ED

P2860

Q53286113-0CC75BDA-EA33-4F39-AE2D-45886755979E

Q53286113-129E7B57-8D56-44D3-AD24-962A12331247

Q53286113-1CBD6D71-4036-46A5-AD61-E9E903FD2241

Q53286113-2A734005-CA0D-4C90-B2F8-007514BD85E6

Q53286113-37B2F87E-3956-4E59-A290-B4DBB7386143

Q53286113-7AC63F1B-9849-4408-AA33-F8ED5390EEFD

Q53286113-98A994EF-5F82-47C6-BF44-DF676959DC1E

Q53286113-A41F418D-E323-42B4-86F7-6900BB1715A0

Q53286113-A71CF965-2DD9-4E7F-B319-D00E9D0FEF15

Q53286113-B0F22821-4B20-48EB-B8EB-8407BBDD3C32

P2888

Q53286113-6CF63259-E7F3-4A69-8851-9393FB195EC7

P304

Q53286113-74A7BB31-AD9B-4F71-98A2-C55DFA26C72A

P31

Q53286113-185D0C98-D4C3-4978-A63E-2BF0A3A9D157

P356

Q53286113-4C0D469E-6EC5-4186-B73B-D57E798975EA

P433

Q53286113-A2AC028F-DC6C-402E-8659-396E13CF3DB7

P478

Q53286113-7E9D917E-303B-46C1-9693-8E6B5C65BF5B

P50

Q53286113-41E0A238-77F2-40CD-BBCA-B2C7B341083B

Q53286113-66321637-0006-4976-9467-D3A267255202

Q53286113-B6A9B090-AA6F-4E59-98D9-B264404E0B91

Q53286113-EC2FD35D-8E12-456C-9221-13CDEDD9A1BC

P577

Q53286113-FB9968EF-85EB-45BD-BBE2-C25DA4566E6D

P6179

Q53286113-B4A40D98-9777-4FFF-A490-00D092285921

P698

Q53286113-4A765168-CFD5-4C45-9B3D-65B9DDC24E6F

P356

S10434-017-5885-4

P1433

Annals of Surgical Oncology

P1476

Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery?

@en

P2093

Alessandro Giardino

http://www.w3.org/2001/XMLSchema#string

Claudio Bassi

http://www.w3.org/2001/XMLSchema#string

Elena Viviani

http://www.w3.org/2001/XMLSchema#string

Filippo Scopelliti

http://www.w3.org/2001/XMLSchema#string

Giovanni Butturini

http://www.w3.org/2001/XMLSchema#string

Isabella Frigerio

http://www.w3.org/2001/XMLSchema#string

Paola Capelli

http://www.w3.org/2001/XMLSchema#string

Paolo Regi

http://www.w3.org/2001/XMLSchema#string

Paolo Tinazzi Martini

http://www.w3.org/2001/XMLSchema#string

Roberto Girelli

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

New Advances in the Treatment of Metastatic Pancreatic Cancer

Metastatic pancreatic cancer: Is there a light at the end of the tunnel?

Cancer statistics, 2016

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer.

Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?

Neoadjuvant therapy of pancreatic cancer: the emerging paradigm?

Pancreatic cancer: from state-of-the-art treatments to promising novel therapies.

Genomic analyses identify molecular subtypes of pancreatic cancer.

P2888

s10434-017-5885-4

P304

2397-2403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-017-5885-4

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Mirko D'Onofrio

Giuseppe Malleo

P577

2017-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085431222

http://www.w3.org/2001/XMLSchema#string

P698

28516291

http://www.w3.org/2001/XMLSchema#string